Taking tirzepatide orally: what the evidence actually says

Is oral tirzepatide available anywhere, and why does it matter?

It's a fair question to ask, and if you're needle-averse or simply hoping for a tablet-based option, you're not alone, a lot of people feel that way when they first look into this. Research into oral formulations of tirzepatide is ongoing, with Eli Lilly running early-phase clinical trials, but no oral tirzepatide product has received regulatory approval from the MHRA or any other major medicines authority at the time of writing. For UK patients, that means there is no licensed oral tirzepatide to prescribe.

The reason this is technically difficult comes down to the molecule itself. Tirzepatide is a large peptide (similar in structure to the gut hormones it mimics) and peptides break down rapidly in stomach acid before they can be absorbed into the bloodstream. Delivering them by injection bypasses this problem entirely. Oral peptide delivery requires specialist absorption enhancers, and pharmaceutical developers are still working on tirzepatide-specific solutions. The NHS medicines page for tirzepatide confirms the subcutaneous injection as the licensed route of administration.

For more background on what tirzepatide is and how it works as a treatment, the tirzepatide overview covers the mechanism, the licensed doses and the clinical trial results in detail.

So can you take Mounjaro orally if you dissolve or open the pen?

No. This question comes up occasionally, and the answer is unambiguous. The Mounjaro KwikPen is designed for subcutaneous injection only. Attempting to consume the solution by any other route (drinking it, applying it topically, or any other improvisation) would expose the active ingredient to conditions that destroy it before it reaches systemic circulation. It would simply have no effect on weight, and handling the pen incorrectly introduces risks from the needle mechanism and from potential contamination.

The question of whether tirzepatide could ever be taken orally in a reformulated product is different from whether the current Mounjaro pen can be repurposed. It cannot. If you want to explore this topic in more depth, the page on oral tirzepatide covers the research landscape and what a licensed oral version would need to look like. There is also a dedicated look at whether tirzepatide can be taken orally that addresses this specific question from a regulatory standpoint.

Is there a licensed oral option for weight loss in the UK right now?

Yes, though it is a different medicine. On 11 June 2026, the MHRA approved Wegovy tablets (oral semaglutide co-formulated with an absorption enhancer called SNAC) making the UK the first country in Europe to license an oral GLP-1 medicine for weight management. This is a meaningful development for people who prefer not to inject.

Wegovy tablets contain semaglutide, not tirzepatide. Semaglutide is a GLP-1 receptor agonist (single pathway), while tirzepatide activates both GIP and GLP-1 receptors. They are distinct medicines with different efficacy profiles; in the SURMOUNT-5 trial published in the New England Journal of Medicine in 2025, tirzepatide produced greater average weight reduction than semaglutide 2.4mg over 72 weeks, though the oral semaglutide maintenance dose of 25mg is higher than the weekly injection's 2.4mg and trial comparisons are not direct. If you're weighing up which approach suits you, the question of oral versus injectable is worth discussing at your consultation. You can read more on the tirzepatide oral form research page or explore how oral tirzepatide formulations work in trials so far.

For a broader look at the UK's licensed weight-loss treatments and how they compare, the weight-loss treatment overview is a useful starting point before a consultation.

What should you do if you've seen oral tirzepatide advertised online?

Treat it as a serious red flag. No oral tirzepatide product is licensed in the UK. Any seller offering one is supplying an unlicensed, unverified product, and the MHRA has documented hospitalisation linked to fake weight-loss injectables containing insulin instead of the labelled medicine. The same risks apply to any unlicensed oral product claiming to be tirzepatide.

Safe access to Mounjaro in the UK means a prescription from a registered prescriber, dispensed by a pharmacy you can verify on the GPhC pharmacy register. At nume, every consultation is reviewed personally by a GPhC-registered Independent Prescriber before any medicine is dispensed. You can also check the Mounjaro price context page for an honest picture of what legitimate private treatment costs and what legitimate providers include in that price. Discount pricing for a prescription medicine from an unverifiable source is not a saving, it is a warning sign.

If you suspect a seller is operating illegally, you can report them at the MHRA's Yellow Card scheme, which accepts reports on both suspected side effects and suspect suppliers.